Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01304485 · ClinicalTrials.gov registry record · Phase 2
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma
A Phase 2 study, sponsored by Phoenix Molecular Imaging.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,000
- Enrollment target
NCT01304485: Completed Phase 2 study, sponsored by Phoenix Molecular Imaging.
NCT01304485 is a Phase 2 study that has completed, run by Phoenix Molecular Imaging. The registered enrollment target is 2,000 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1404% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01304485, a Phase 2 study, has completed, sponsored by Phoenix Molecular Imaging.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,000 participants
- Enrollment target
Study Summary
Positron emission tomography (PET) imaging evaluation in men with recurrent prostate cancer to select patients who may benefit from directed therapy
Primary Outcome
Imaging studies will be evaluated both qualitatively and quantitatively using SUV (standardized uptake values): a measure of metabolism based on injected dose, patient weight and region of interest.
Interventions
- DRUG Sodium Acetate C11
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2011-04 |
| Est. Completion | 2019-01 |
| Phase | Phase 2 |
What the finished NCT01304485 record still lists
NCT01304485 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1404% higher).
The record links to 0 conditions, and to 1 intervention - of which Sodium Acetate C11 is the first listed.
NCT01304485 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01304485 about?
NCT01304485 is a clinical study titled "PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma". Positron emission tomography (PET) imaging evaluation in men with recurrent prostate cancer to select patients who may benefit from directed therapy
What is the current status of trial NCT01304485?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,000 participants. The study started on 2011-04. Estimated completion is 2019-01.
What interventions are being tested in trial NCT01304485?
The interventions under investigation include: Sodium Acetate C11 (DRUG).
Who is sponsoring clinical trial NCT01304485?
This trial is sponsored by Phoenix Molecular Imaging, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01304485's enrollment target sits among peer trials
2,000 8th of 2000 higher than 1,992 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia